-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Data monitoring committees in clinical trials: best practice, complexities and considerations
Simon Day
Editorial: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Clinical trials: beyond efficiency-why are we flying blind?
Greg Koski, Matthew Whalen
Opinion Article: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Placebo effects in children
Katja Weimer, Paul Enck,
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Novel therapeutics for cystic fibrosis: what does the future hold?
Carlos E Milla
Editorial: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 8
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation Vol 3, Iss 5
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Acknowledgements: Clinical Investigation (2012) Vol 2, Iss 11
Acknowledgements: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of linaclotide for the treatment of irritable syndrome
JR Malagelada
Review: Clinical Trail Outcomes: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Challenges and opportunities in the design and implementation of breast cancer clinical trials in the developing countries
Sudeep Gupta, Shona Nag, Shaheenah Dawood
Clinical Trail Perspective: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation